MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,251,696 | +80.8% | 1,038,836 | +50.1% | 0.14% | +101.4% |
Q2 2023 | $25,030,834 | -5.1% | 692,033 | -2.5% | 0.07% | -8.9% |
Q1 2023 | $26,380,214 | -15.9% | 709,527 | +2.4% | 0.08% | -19.4% |
Q4 2022 | $31,384,289 | -15.7% | 692,657 | +29.9% | 0.10% | -26.9% |
Q3 2022 | $37,249,000 | +2.7% | 533,350 | -1.2% | 0.13% | +24.1% |
Q2 2022 | $36,255,000 | +57.1% | 540,085 | +92.4% | 0.11% | +80.0% |
Q1 2022 | $23,081,000 | – | 280,717 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |